C. Fragiacomo
About
In The Last Decade
C. Fragiacomo
25 papers receiving 784 citations
Peers
Comparison fields: 5 of 78
- Rheumatology 255
- Physiology 249
- Surgery 168
- Nutrition and Dietetics 156
- Molecular Biology 154
Countries citing papers authored by C. Fragiacomo
This map shows the geographic impact of C. Fragiacomo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Fragiacomo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Fragiacomo more than expected).
Fields of papers citing papers by C. Fragiacomo
This network shows the impact of papers produced by C. Fragiacomo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Fragiacomo. The network helps show where C. Fragiacomo may publish in the future.
Co-authorship network of co-authors of C. Fragiacomo
This figure shows the co-authorship network connecting the top 25 collaborators of C. Fragiacomo. A scholar is included among the top collaborators of C. Fragiacomo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Fragiacomo. C. Fragiacomo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 64 | |
| 2 | 265 | |
| 3 | 54 | |
| 4 | 73 | |
| 5 | 24 | |
| 6 | 11 | |
| 7 | [Pravastatin in the treatment of primary hypercholesterolemia: a Swiss multicenter study]. | 4 |
| 8 | Aortic and coronary atheromatosis in a woman with severe hypercholesterolaemia without LDL receptor alterations. | 12 |
| 9 | 2 | |
| 10 | 15 | |
| 11 | 21 | |
| 12 | 50 | |
| 13 | 14 | |
| 14 | 39 | |
| 15 | [Effective long-term treatment of primary hyperlipoproteinemias with bezafibrate]. | 3 |
| 16 | [Modification of serum lipids, lipoproteins and apoproteins AI and B in patients with hyperlipidemia Type IIa and IIb using polyenylphosphatidylcholine]. | 4 |
| 17 | 36 | |
| 18 | 5 | |
| 19 | [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types]. | 1 |
| 20 | 101 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.